Patient Understanding of LiverMultiScan

Overview

This is a qualitative study to determine which factors affect the patient experience of having a liver MRI, what information patients would like to receive after their MRI, and how patients would like this information communicated to them.

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Other
  • Study Primary Completion Date: December 2017

Detailed Description

This is a qualitative study to determine which factors affect the patient experience of having a liver MRI, what information patients would like to receive after their MRI, and how patients would like this information communicated to them. Each individual will receive at least an MRI scan (LiverMultiScan), with many also receiving a FibroScan (Transient Elastography). Patients will then undergo a focused qualitative interview, as well as filling out a questionnaire. The interviews will be thematically analysed and trends identified by significance.

Interventions

  • Device: MRI
  • Device: Transient Elastography

Arms, Groups and Cohorts

  • Experience of liver disease
    • This is defined as either those who have had direct experience of liver disease as sufferers, or the carers of those who have had liver disease. Each individual receives an MRI (LiverMultiScan), with many also receiving a FibroScan.

Clinical Trial Outcome Measures

Primary Measures

  • Factors effecting MRI experience and understanding.
    • Time Frame: Immediately (within 1 hour) after undergoing the MRI scan, and receiving results feedback.
    • This will be analysed based on themes and trends emanating from answers within the focused interview and questionnaire following the scan, and results feedback.

Secondary Measures

  • Comparison of MRI to ultrasound scan in terms of patient experience.
    • Time Frame: Immediately (within 1 hour) after undergoing an MRI scan, and ultrasound (FibroScan) scan.
    • This will be analysed based on themes and trends emanating from answers within the focused interview and questionnaire following the scan, and results feedback.

Participating in This Clinical Trial

Inclusion Criteria

  • Individuals with experience of liver disease. – Individuals over the age of 16. – Individuals willing to give informed consent for participation in the study. Exclusion Criteria:

  • Individuals with any contraindication to magnetic resonance imaging.

Gender Eligibility: All

Minimum Age: 16 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • Perspectum
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Rajarshi Banerjee, BM BCh MRCP MSc DPhil, Principal Investigator, Perspectum Diagnostics

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.